Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts.
A range of tissue types has now been targeted for development of gene therapeutic procedures both to correct genetic defects and to treat acquired disease. In particular, skeletal muscle holds great importance, not exclusively for the treatment of inherited muscle disorders but also as a platform for the expression of heterologous recombinant proteins, destined to immunise the host or to serve some systemic therapeutic goal. With respect to the X-linked myopathy Duchenne muscular dystrophy (DMD), several gene therapy protocols are being developed that focus on complementing primary genetic defects in the DMD gene by introducing copies of recombinant gene constructs into muscle cells both ex vivo and in vivo. In the present study the potential use of a range of polycationic liposomes as physical gene delivery systems for skeletal muscle has been examined. Using a LacZ reporter gene under optimised conditions up to 40% transfection efficiencies were obtained with the mouse myoblast cell line C2C12. With primary cultures of normal and dystrophin-deficient mdx mouse muscle, up to 10% transfection efficiency was obtained with reporter gene constructs, and high levels of recombinant human dystrophin expression were observed following transfer of dystrophin cDNA gene constructs. These in vitro studies indicate that cationic liposomes can be used to deliver recombinant genes to muscle cells at high efficiency and form a basis to expand investigations into in vivo expression of recombinant dystrophin protein either by direct intramuscular gene transfer or via implantation of transfected myoblasts.
Trivedi
R A
RA
Department of Experimental Pathology, UMDS, Guys Hospital, London Bridge, England.
Dickson
G
G
D000818:Animals; D002478:Cells, Cultured; D016189:Dystrophin / Q000172:deficiency / Q000235:genetics*; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D015316:Genetic Therapy; D007202:Indicators and Reagents; D008081:Liposomes / Q000378:metabolism*; D051379:Mice; D008817:Mice, Mutant Strains; D009132:Muscles / Q000378:metabolism / Q000648:ultrastructure; D009137:Muscular Dystrophy, Animal / Q000235:genetics* / Q000628:therapy; D011994:Recombinant Proteins; D014162:Transfection
D016189:Dystrophin; D007202:Indicators and Reagents; D008081:Liposomes; D011994:Recombinant Proteins